山东大学教师主页程艳娜 LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin 中文主页

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin: 发布时间：2019-10-22 | 点击次数：

所属单位：药学院

发表刊物：《Invest New Drugs》

第一作者：曲显俊

全部作者：程艳娜

论文类型：基础研究

论文编号：lw-104094

卷号：29

期号：12

页面范围：574

是否译文：否

发表时间：2011-08

上一条： Modulation of P-glycoprotein activity by the substituted quinoxalinone compound QA3 in adriamycin-resistant K562/A02 cells

下一条： LYP, a bestatin dimethylaminoethyl ester, inhibited cancer angiogenesis both in vitro and in vivo